Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-02-14 9:02 pm Purchase | 13G | REPARE THERAPEUTICS INC RPTX | Blue Owl Capital Holdings LP | 3,122,499 7.41% | 3,122,499 (New Position) | View |
2024-02-14 4:26 pm Sale | 13G | REPARE THERAPEUTICS INC RPTX | Redmile Group LLC | 2,148,748 5.1% | -535,648 (-19.95%) | View |
2024-02-14 08:54 am Purchase | 13G | REPARE THERAPEUTICS INC RPTX | Deep Track Capital LP | 2,992,731 7.1% | 265,125 (+9.72%) | View |
2024-01-29 4:01 pm Purchase | 13G | REPARE THERAPEUTICS INC RPTX | ARK Investment Management LLC | 2,821,560 6.7% | 393,505 (+16.21%) | View |
2023-11-17 4:52 pm Purchase | 13D | REPARE THERAPEUTICS INC RPTX | BIOTECHNOLOGY VALUE FUND L P | 10,333,600 24.5% | 1,235,000 (+13.57%) | View |
2023-11-03 5:20 pm Purchase | 13D | REPARE THERAPEUTICS INC RPTX | BIOTECHNOLOGY VALUE FUND L P | 9,098,600 21.6% | 806,612 (+9.73%) | View |
2023-02-14 4:29 pm Sale | 13G | REPARE THERAPEUTICS INC RPTX | Redmile Group LLC | 2,684,396 6.4% | -105,100 (-3.77%) | View |
2023-02-14 12:38 pm Sale | 13G | REPARE THERAPEUTICS INC RPTX | PRICE T ROWE ASSOCIATES INC | 26,894 0.1% | -2,139,928 (-98.76%) | View |
2023-02-14 08:57 am Purchase | 13G | REPARE THERAPEUTICS INC RPTX | Deep Track Capital LP | 2,727,606 6.5% | 627,606 (+29.89%) | View |
2023-02-13 5:55 pm Purchase | 13G | REPARE THERAPEUTICS INC RPTX | BIOTECHNOLOGY VALUE FUND L P | 8,291,988 19.8% | 150,000 (+1.84%) | View |
2023-02-13 12:07 pm Purchase | 13G | REPARE THERAPEUTICS INC RPTX | CHI Advisors LLC | 2,800,126 6.67% | 587,870 (+26.57%) | View |
2023-02-10 2:05 pm Sale | 13G | REPARE THERAPEUTICS INC RPTX | ARK Investment Management LLC | 2,428,055 5.79% | -552,781 (-18.54%) | View |
2023-02-09 12:31 pm Sale | 13G | REPARE THERAPEUTICS INC RPTX | FMR LLC | 876,178 2.088% | -2,145,135 (-71.00%) | View |
2023-01-06 4:19 pm Sale | 13D | REPARE THERAPEUTICS INC RPTX | Versant Venture Capital V L.P. | 2,094,451 5% | -250,000 (-10.66%) | View |
2022-06-13 4:38 pm Sale | 13D | REPARE THERAPEUTICS INC RPTX | Versant Venture Capital V L.P. | 2,344,451 5.6% | -250,000 (-9.64%) | View |
2022-06-06 5:25 pm Purchase | 13G | REPARE THERAPEUTICS INC RPTX | BIOTECHNOLOGY VALUE FUND L P | 8,141,988 19.4% | 3,283,227 (+67.57%) | View |
2022-02-14 5:07 pm Purchase | 13G | REPARE THERAPEUTICS INC RPTX | Redmile Group LLC | 2,789,496 6.7% | 141,800 (+5.36%) | View |
2022-02-14 2:35 pm Purchase | 13G | REPARE THERAPEUTICS INC RPTX | PRICE T ROWE ASSOCIATES INC | 2,166,822 5.1% | 2,166,822 (New Position) | View |
2022-02-14 09:00 am Sale | 13G | REPARE THERAPEUTICS INC RPTX | Deep Track Capital LP | 2,100,000 5.03% | -4,600 (-0.22%) | View |
2022-02-11 9:11 pm Purchase | 13G | REPARE THERAPEUTICS INC RPTX | BIOTECHNOLOGY VALUE FUND L P | 4,858,761 11.6% | 1,136,363 (+30.53%) | View |